Edition:
India

Cipher Pharmaceuticals Expects Q2 2019 Earnings Per Share In Range Of $0.04 To $0.05


Monday, 29 Jul 2019 

July 29 (Reuters) - Cipher Pharmaceuticals Inc ::CIPHER PHARMACEUTICALS ANNOUNCES MANAGEMENT CHANGE & PRELIMINARY Q2 FINANCIAL HIGHLIGHTS.CIPHER PHARMACEUTICALS INC - CRAIG MULL HAS BEEN NAMED INTERIM CHIEF EXECUTIVE OFFICER OF CIPHER, REPLACING ROBERT TESSAROLO.CIPHER PHARMACEUTICALS INC - CO HAS COMMENCED A FORMAL SEARCH PROCESS FOR A NEW CHIEF EXECUTIVE OFFICER.CIPHER PHARMACEUTICALS INC - EXPECTS Q2 2019EARNINGS PER SHARE IN RANGE OF $0.04 TO $0.05.CIPHER PHARMACEUTICALS INC - SEES Q2 2019 REVENUE IN RANGE OF $5.4 MILLION TO $5.6 MILLION, COMPARED WITH $6.95 MILLION IN Q2 2018.